These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Conditional somatic mutagenesis in the mouse using site-specific recombinases. Feil R Handb Exp Pharmacol; 2007; (178):3-28. PubMed ID: 17203649 [TBL] [Abstract][Full Text] [Related]
3. Site-specific recombinases for manipulation of the mouse genome. Birling MC; Gofflot F; Warot X Methods Mol Biol; 2009; 561():245-63. PubMed ID: 19504076 [TBL] [Abstract][Full Text] [Related]
4. Engineering embryonic stem cells with recombinase systems. Schnütgen F; Stewart AF; von Melchner H; Anastassiadis K Methods Enzymol; 2006; 420():100-36. PubMed ID: 17161696 [TBL] [Abstract][Full Text] [Related]
5. A practical summary of site-specific recombination, conditional mutagenesis, and tamoxifen induction of CreERT2. Anastassiadis K; Glaser S; Kranz A; Berhardt K; Stewart AF Methods Enzymol; 2010; 477():109-23. PubMed ID: 20699139 [TBL] [Abstract][Full Text] [Related]
6. Impact of brain-behavior phenotypying of genetically-engineered mice on research of neuropsychiatric disorders. Takao K; Yamasaki N; Miyakawa T Neurosci Res; 2007 Jun; 58(2):124-32. PubMed ID: 17524507 [TBL] [Abstract][Full Text] [Related]
7. Engineering subtle targeted mutations into the mouse genome. Menke DB Genesis; 2013 Sep; 51(9):605-18. PubMed ID: 23913666 [TBL] [Abstract][Full Text] [Related]
8. Of mice and models: improved animal models for biomedical research. Bockamp E; Maringer M; Spangenberg C; Fees S; Fraser S; Eshkind L; Oesch F; Zabel B Physiol Genomics; 2002 Dec; 11(3):115-32. PubMed ID: 12464688 [TBL] [Abstract][Full Text] [Related]
9. New technologies provide insights into genetic basis of psychiatric disorders and explain their co-morbidity. Rudan I Psychiatr Danub; 2010 Jun; 22(2):190-2. PubMed ID: 20562745 [TBL] [Abstract][Full Text] [Related]
10. The genes and brains of mice and men. Tecott LH Am J Psychiatry; 2003 Apr; 160(4):646-56. PubMed ID: 12668350 [TBL] [Abstract][Full Text] [Related]
11. Modelling the genetic contribution to mental illness: a timely end for the psychiatric rodent? Davis BA; Isles AR Eur J Neurosci; 2014 Jun; 39(11):1933-42. PubMed ID: 24862335 [TBL] [Abstract][Full Text] [Related]
12. Polishing the craft of genetic diversity creation in directed evolution. Tee KL; Wong TS Biotechnol Adv; 2013 Dec; 31(8):1707-21. PubMed ID: 24012599 [TBL] [Abstract][Full Text] [Related]
14. Dre recombinase, like Cre, is a highly efficient site-specific recombinase in E. coli, mammalian cells and mice. Anastassiadis K; Fu J; Patsch C; Hu S; Weidlich S; Duerschke K; Buchholz F; Edenhofer F; Stewart AF Dis Model Mech; 2009; 2(9-10):508-15. PubMed ID: 19692579 [TBL] [Abstract][Full Text] [Related]
15. Why genetic investigation of psychiatric disorders is so difficult. Bearden CE; Reus VI; Freimer NB Curr Opin Genet Dev; 2004 Jun; 14(3):280-6. PubMed ID: 15172671 [TBL] [Abstract][Full Text] [Related]
16. Cross-species behavioural genetics: A starting point for unravelling the neurobiology of human psychiatric disorders. de Mooij-van Malsen AJ; Vinkers CH; Peterse DP; Olivier B; Kas MJ Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(6):1383-90. PubMed ID: 20955750 [TBL] [Abstract][Full Text] [Related]
17. Reverse genetic approaches in zebrafish. Huang P; Zhu Z; Lin S; Zhang B J Genet Genomics; 2012 Sep; 39(9):421-33. PubMed ID: 23021542 [TBL] [Abstract][Full Text] [Related]
18. Dissection of behavior and psychiatric disorders using the mouse as a model. Tarantino LM; Bucan M Hum Mol Genet; 2000 Apr; 9(6):953-65. PubMed ID: 10767319 [TBL] [Abstract][Full Text] [Related]